News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
150 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33091)
2026 (17234)
Month
January (2936)
February (2968)
March (2710)
April (2908)
May (3626)
June (2409)
July (2088)
August (2590)
September (2381)
October (3064)
November (3189)
December (2222)
Day
1 (150)
2 (126)
3 (95)
5 (29)
6 (105)
7 (106)
8 (131)
9 (140)
10 (84)
13 (72)
14 (99)
15 (146)
16 (136)
17 (106)
19 (47)
20 (160)
21 (172)
22 (150)
23 (144)
24 (76)
26 (1)
27 (133)
28 (187)
29 (139)
30 (128)
31 (202)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
5
6
7
8
9
10
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
31
Press Releases
LAVA Therapeutics to Move Extraordinary General Meeting to Early November 2025
October 1, 2025
·
7 min read
Press Releases
Kynexis Announces First Patient Dosed in Phase 2 Clinical Trial of KYN-5356 for Cognitive Impairment Associated With Schizophrenia
October 1, 2025
·
3 min read
Press Releases
ENHERTU® Followed by THP Supplemental Biologics License Application Accepted in the U.S. for Patients with High-Risk HER2 Positive Early-Stage Breast Cancer Prior to Surgery
October 1, 2025
·
19 min read
Press Releases
Ocular Therapeutix™ Announces Pricing of Underwritten Offering of Common Stock
October 1, 2025
·
5 min read
Press Releases
C4 Therapeutics Announces Clinical Trial Collaboration and Supply Agreement with Pfizer for the Combination of Cemsidomide and Elranatamab for the Treatment of Relapsed/Refractory Multiple Myeloma
October 1, 2025
·
5 min read
Press Releases
Avalo Therapeutics Expands Leadership Team with Key Appointments in Business Development and Human Resources
October 1, 2025
·
7 min read
Press Releases
AIRNA Appoints Allison Dorval as Chief Financial Officer and Niru Subramanian as Chief Operating Officer
October 1, 2025
·
2 min read
Press Releases
Climb Bio Appoints Susan Altschuller, Ph.D., MBA as Chief Financial Officer
October 1, 2025
·
6 min read
Press Releases
Medicenna Therapeutics to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
October 1, 2025
·
4 min read
Press Releases
OmniaBio Inc. and BrainChild Bio Announce Collaboration to Accelerate CAR-T Cell therapy Development in Brain Cancer
October 1, 2025
·
3 min read
Previous
12 of 15
Next